Answers are grounded in this paper and cite their sources.
Background Diabetic retinopathy (DR) is a major microvascular complication of type 2 diabetes mellitus (T2DM), with emerging evidence suggesting early retinal neurodegeneration preceding vascular changes. Optical coherence tomography (OCT) enables noninvasive evaluation of ganglion cell complex (GCC), retinal nerve fiber layer (RNFL), and central macular thickness (CMT), potential biomarkers for diabetic retinal neurodegeneration (DRN). Aim To assess neurodegeneration in cases with T2DM with and without DR by OCT by measuring RNFL thickness and GCC thickness and CMT in diabetic cases with and without DR in comparison to nondiabetics. Patients and methods This research is case-control analytic research; including 124 eyes of 62 patients, subdivided into 21 T2DM patients without DR (group A) and 21 T2DM patients with DR (Group B) compared with 20 healthy population (group C). We measured average RNFL, GCC and CMT in each group. Data was collected within the period from February to October 2023. Results A statistically insignificant variance in the average RNFL thickness has been observed between the three groups. However, the average GCC and CMT were significantly thicker in group B compared with both group A and group C ( P <0.05). Insignificant variances in GCC and CMT were observed between diabetic cases without DR and the control group. A significant positive association was identified between CMT and glycosylated hemoglobin levels ( P =0.025). Conclusion GCC and CMT were significantly thicker in diabetic cases with established retinopathy, whereas insignificant changes in RNFL, GCC, or CMT were found in diabetics without retinopathy compared with controls. This suggests neurodegenerative changes may become more apparent in later stages of DR.
No takes yet. Share an insight, caveat, or question.
Noureldine et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: